Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: Achilles’ Last Stand?

Daniel W. Carlson, Ronald D. Berger

Research output: Contribution to journalEditorialpeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)1484-1486
Number of pages3
JournalJACC: Clinical Electrophysiology
Issue number13
StatePublished - Dec 26 2017


  • device infection
  • implantable cardioverter-defibrillator shock
  • inappropriate therapy
  • subcutaneous implantable cardioverter
  • transvenous implantable cardioverter-defibrillator

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this